Douglas E. Williams - Mar 31, 2025 Form 4 Insider Report for Climb Bio, Inc. (CLYM)

Role
Director
Signature
Emily Pimblett, as Attorney-in-Fact
Stock symbol
CLYM
Transactions as of
Mar 31, 2025
Transactions value $
$0
Form type
4
Date filed
4/1/2025, 04:23 PM
Previous filing
Mar 19, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLYM Stock Option (Right to Buy) Award $0 +78.9K $0.00 78.9K Mar 31, 2025 Common Stock 78.9K $1.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option vest in equal monthly installments from November 8, 2024 (the "Vesting Commencement Date") until the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service.